We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
22 May 2021 - 26 May 2021
Virtual Venue

Electron Canon Purifies Indoor Environments

By HospiMedica International staff writers
Posted on 04 May 2021
Print article
Image: The Shycocan device emits an electron stream to disrupt virus transmission (Photo courtesy of SSTx)
Image: The Shycocan device emits an electron stream to disrupt virus transmission (Photo courtesy of SSTx)
A novel virus deactivation system uses an extremely high-intensity discharge of electrons to actively impede air and surface transmission of the Corona family of viruses.

The Shreis Scalene Therapeutics (SSTx; Gaithersburg, MD, USA) scalene hypercharge corona canon (Shycocan) uses proprietary photon-mediated electron emitters (PMEEs) to discharge trillions of electrons every second. The intense kinetic energy impedes the negative-charge seeking mechanism of the SARS-CoV-2 spike protein, actively disarming air and surface transmission. Shycocan does not use any chemicals, and does not produce ozone, reactive oxygen species (ROS), oxides of nitrogen, or other harmful compounds.

The technology is based on a super alloy, scalene, that release the hypercharged electrons. The plug and play device requires no setup, except for mounting on side wall, pedestal, or table-top, and access to a power outlet. Once turned on, Shycocan begins working instantaneously. The device can be deployed in all environments, and does not interfere with other electronic devices such as air conditioning or cellular communications. It is also being studied for use in farms to prevent the transmission of the G4-EA-H1N1 virus, described as being highly adapted to infect humans.

“No ultraviolet light, filter-systems, hazardous ozone, or other harmful chemical emission occurs with the Shycocan,” said Professor Meena Augustus PhD, founder, president, CEO, and CSO of SSTx. “A salient feature of this technology, that has also been biologically validated, is that while viruses are targeted, beneficial bacteria, fungi or other micro-organisms, human and mammalian epithelial cells are not, making it eco-, people, and pet friendly.”

Related Links:
Shreis Scalene Therapeutics

Print article


Copyright © 2000-2021 Globetech Media. All rights reserved.